Jesus Reine

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

Journal: Virulence

Published: July 15, 2026

Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro.

Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro.

Journal: Virology

Published: March 25, 2026

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Journal: Computational biology and chemistry

Published: November 25, 2025

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Journal: Vaccine

Published: November 12, 2025

Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.

Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.

Journal: Virus research

Published: November 06, 2025

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Journal: The Journal of infectious diseases

Published: August 29, 2025

A retrospective computational validation of a clinically evaluated recombinant envelope protein tetravalent dengue vaccine.

A retrospective computational validation of a clinically evaluated recombinant envelope protein tetravalent dengue vaccine.

Journal: International journal of biological macromolecules

Published: July 09, 2025

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Journal: Cell reports

Published: May 12, 2025

In Vitro Characterization of the Immune Response to an Epitope Ensemble Vaccine Against Rhinovirus in Pediatric Asthma and Adults With Chronic Obstructive Pulmonary Disease: Protocol for an Observational and Exploratory Study.

In Vitro Characterization of the Immune Response to an Epitope Ensemble Vaccine Against Rhinovirus in Pediatric Asthma and Adults With Chronic Obstructive Pulmonary Disease: Protocol for an Observational and Exploratory Study.

Journal: JMIR research protocols

Published: March 04, 2025

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Journal: The Lancet. Microbe

Published: September 05, 2024

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs.

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs.

Journal: Nucleic acids research

Published: July 30, 2024

Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.

Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.

Journal: Frontiers in immunology

Published: April 29, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026